Askel Healthcare Ltd granted Breakthrough Device Designation by the FDA

We are very pleased to learn that our Finnish start-up client Askel Healthcare Ltd was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for their COPLA® cartilage repair device.

Ylva Skoglösa tells the full story.